NCT06034028View on ClinicalTrials.gov

J-Valve TF Early Feasibility Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

October 16, 2023

Primary Completion Date

July 17, 2024

Study Completion Date

August 25, 2029

Conditions
Aortic Valve DiseaseAortic Valve InsufficiencyAortic Regurgitation
Interventions
DEVICE

J-Valve TF System

The J-Valve TF System is a transcatheter aortic valve replacement system that consists of the J-Valve TF Bioprosthesis, J-Valve TF Delivery Device, and Loading Accessories.

Trial Locations (9)

10467

Montefiore Medical Center, The Bronx

14203

University at Buffalo, Buffalo

20010

MedStar Washington Hospital Center, Washington D.C.

45219

The Christ Hospital, Cincinnati

60453

Advocate Christ Medical Center, Oak Lawn

70360

Cardiovascular Institute of the South, Houma

77030

Houston Methodist Hospital, Houston

85258

HonorHealth, Scottsdale

98122

Swedish Medical Center Cherry Hill, Seattle

All Listed Sponsors
lead

JC Medical, Inc., an affiliate of Edwards Lifesciences LLC

INDUSTRY